No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
INCY Incyte
- 62.110
- -0.580-0.93%
Close Jun 14 16:00 ET
- 62.120
- +0.010+0.02%
Post 18:38 ET
12.24BMarket Cap18.82P/E (TTM)
63.080High61.420Low4.89MVolume62.280Open62.690Pre Close303.69MTurnover3.08%Turnover Ratio23.44P/E (Static)197.01MShares67.36552wk High2.27P/B9.88BFloat Cap50.27052wk Low--Dividend TTM159.04MShs Float153.150Historical High--Div YieldTTM2.65%Amplitude1.850Historical Low62.077Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Insider Sale: EVP & General Manager US Barry Flannelly Sells 19,164 Shares of Incyte Corp (INCY)
Incyte(INCY.US) Officer Sells US$1.15 Million in Common Stock
$Incyte(INCY.US)$ Officer Flannelly Barry P sold 19,164 shares of common stock on Jun 12, 2024 at an average price of $60 for a total value of $1.15 million.Source: Announcement What is statement of c
Incyte Insider Sold Shares Worth $1,149,840, According to a Recent SEC Filing
Barry P Flannelly, Executive Vice President & General Manager, US, on June 12, 2024, sold 19,164 shares in Incyte (INCY) for $1,149,840. Following the Form 4 filing with the SEC, Flannelly has control
Nasdaq 100, S&P 500 Close At Record Highs As Tech Stocks Reclaim Dominance: Thursday's Gainers & Losers
The Nasdaq 100 index posted its fourth consecutive session in the green on Thursday, closing up 0.6% at 19,576 points and reaching new all-time highs as tech stocks drive broader market gains.The S&P
Express News | Incyte Announces Final Results of Tender Offer
Form 144 | Incyte(INCY.US) Officer Proposes to Sell 1.15 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 12, $Incyte(INCY.US)$ Officer BARRY P FLANNELLY intends to sell 19,164 shares of its common stock on Jun 12, with a total market value of approximately $1.15 million. So
Comments
This month was a really chaotic month for me as it was very volatile with huge ups and downs.
My three biggest winners this month were INCY, APPL, and NVDA. Although my P/L could be higher if I did not sell my NVDA early, I still managed to reap the 5% gain in NVDA.
I believe NVDA holds massive growth potential as many companies have started shifting to NVDA, and AI hype will not seem to die down so soon. I will be expecting around 30 billion in revenue next quarter, which led me to buy ...
My three biggest winners this month were INCY, APPL, and NVDA. Although my P/L could be higher if I did not sell my NVDA early, I still managed to reap the 5% gain in NVDA.
I believe NVDA holds massive growth potential as many companies have started shifting to NVDA, and AI hype will not seem to die down so soon. I will be expecting around 30 billion in revenue next quarter, which led me to buy ...
11
5
This month was a really chaotic month for me as it was very volatile with huge ups and downs.
My three biggest winners this month were INCY, APPL, and NVDA. Although my P/L could be higher if I did not sell my NVDA early, I still managed to reap the 5% gain in NVDA.
I believe NVDA holds massive growth potential as many companies have started shifting to NVDA, and AI hype will not seem to die down so soon. I will be expecting around 30 billion in revenue next quarter, which led ...
My three biggest winners this month were INCY, APPL, and NVDA. Although my P/L could be higher if I did not sell my NVDA early, I still managed to reap the 5% gain in NVDA.
I believe NVDA holds massive growth potential as many companies have started shifting to NVDA, and AI hype will not seem to die down so soon. I will be expecting around 30 billion in revenue next quarter, which led ...
8
» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte(INCY.US$
$BeiGene(BGNE.US$
$ACADIA Pharmaceuticals(ACAD.US$
$Madrigal Pharmaceuticals(MDGL.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Revolution Medicines(RVMD.US$
$Kymera Therapeutics(KYMR.US$
$AbCellera Biologics(ABCL.US$
$Bicycle Therapeutics(BCYC.US$
$Edgewise Therapeutics(EWTX.US$
$Immunocore(IMCR.US$
$Kodiak Sciences(KOD.US$
$Roivant Sciences(ROIV.US$
...
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte(INCY.US$
$BeiGene(BGNE.US$
$ACADIA Pharmaceuticals(ACAD.US$
$Madrigal Pharmaceuticals(MDGL.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Revolution Medicines(RVMD.US$
$Kymera Therapeutics(KYMR.US$
$AbCellera Biologics(ABCL.US$
$Bicycle Therapeutics(BCYC.US$
$Edgewise Therapeutics(EWTX.US$
$Immunocore(IMCR.US$
$Kodiak Sciences(KOD.US$
$Roivant Sciences(ROIV.US$
...
6
Meme stock volatility hit the market Monday, sending indexes higher, but shortly before noon EST, the market boomeranged back down. Just after the closing bell, the $S&P 500 Index(.SPX.US$ had fallen flatly 0.02%, the $Dow Jones Industrial Average(.DJI.US$ also declined 0.17%, and the $Nasdaq Composite Index(.IXIC.US$ climbed 0.28%.
MACRO
This week, investors can expect macroeconomic data prints in the form of PPI on Tuesday, and CPI prints Wednesd...
MACRO
This week, investors can expect macroeconomic data prints in the form of PPI on Tuesday, and CPI prints Wednesd...
+1
28
4
Morning Movers
Gapping up
$GameStop(GME.US$ shares surged over 37% in the premarket after "Roaring Kitty" posted for the first time in roughly three years.
$Arm Holdings(ARM.US$ shares increased by 3.4% following a report that the chip company plans to launch its first artificial intelligence chips next year.
$NVIDIA(NVDA.US$ shares added about 1% after Jefferies hiked its price target on the chipmaker to $1,200 a share, im...
Gapping up
$GameStop(GME.US$ shares surged over 37% in the premarket after "Roaring Kitty" posted for the first time in roughly three years.
$Arm Holdings(ARM.US$ shares increased by 3.4% following a report that the chip company plans to launch its first artificial intelligence chips next year.
$NVIDIA(NVDA.US$ shares added about 1% after Jefferies hiked its price target on the chipmaker to $1,200 a share, im...
26
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Elons Pube : Do you do option trading?
DouGieeOP Elons Pube: no options. just overnight trading explain 22nd and 23rd
Elons Pube DouGieeOP: What do you mean by explain 22nd and 23rd
DouGieeOP Elons Pube: sorry i means "which explains 22nd and 23rd"
Elons Pube DouGieeOP: Thanks